Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.
Hepatic Sinusoidal Obstruction Syndrome (HSOS), the new name given to veno-occlusive disease (VOD) of the liver, is a well-known complication of high-dose chemotherapy employed with hematopoietic stem cell transplantation, but it has rarely been observed in children who receive conventional chemotherapy. HSOS following standard chemotherapy has been reported in patients receiving vincristine, actinomycin D, and cyclophosphamide for the treatment of Wilms tumor and more rarely rhabdomyosarcoma. We report a 14-year-old boy with high risk medulloblastoma treated with craniospinal radiation followed by chemotherapy, who experienced severe HSOS after only one course of chemotherapy including carboplatin, vincristine, and cyclophosphamide. To our knowledge, this is the second report of HSOS after standard dose chemotherapy for brain tumor in childhood.
Ishaqi
M Kashif
MK
Division of Pediatric Hematology/Oncology, Tawam Hospital, Johns Hopkins Medicine, Al-Ain, United Arab Emirates. kishaqi@hotmail.com
Jamil
A
A
Khanani
M
M
Baroudi
M
M
Trad
Omar
O
El-Hayek
M
M
Bouffet
Eric
E
D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000188:drug therapy; D003131:Combined Modality Therapy / Q000009:adverse effects*; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine
J Clin Oncol. 1998 Jan;16(1):222-8
9440746
Eur J Cancer. 1998 Jul;34(8):1220-3
9849483
Pediatr Blood Cancer. 2006 Apr;46(4):521-3
16317738
Med Pediatr Oncol. 1997 Oct;29(4):245-51
9251728
Bone Marrow Transplant. 2005 Dec;36(11):939-45
16184181
Ann Intern Med. 1979 Feb;90(2):158-64
36019
Bone Marrow Transplant. 2001 Nov;28(9):895-7
11781652
Transplantation. 1987 Dec;44(6):778-83
3321587
Med Pediatr Oncol. 1991;19(4):295-300
2056973
J Natl Cancer Inst. 2003 Oct 15;95(20):1548-51
14559878
Med Pediatr Oncol. 2003 Jul;41(1):44-8
12764742
Eur J Pediatr Surg. 2000 Oct;10(5):300-3
11194540
Ann Intern Med. 1993 Feb 15;118(4):255-67
8420443
Pediatr Hematol Oncol. 2007 Dec;24(8):615-21
18092252
Med Pediatr Oncol. 1995 May;24(5):334-40
7700188
Hepatology. 1984 Jan-Feb;4(1):116-22
6363247
Blood. 2004 Apr 1;103(7):2554-9
14670928
J Clin Oncol. 1990 Sep;8(9):1525-30
2167951
Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):477-84
9231669
Arch Pathol Lab Med. 1985 Apr;109(4):367-9
2985019
Transplant Proc. 2005 Jun;37(5):2285-9
15964400
J Pediatr Hematol Oncol. 2004 Jan;26(1):52-5
14707715
Mayo Clin Proc. 2003 May;78(5):589-98
12744547
J Pediatr Hematol Oncol. 2003 Mar;25(3):248-51
12621246
Pediatr Blood Cancer. 2009 Aug;53(2):208-10
19373780
Cancer. 2008 Mar 15;112(6):1345-53
18224664
Cell Cycle. 2007 Oct 15;6(20):2453-7
17786054
Bone Marrow Transplant. 2000 May;25(9):993-6
10800069
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1031-7
16343801
Hepatology. 1994 May;19(5):1171-81
8175139
Cancer. 1997 Jun 15;79(12):2435-9
9191535
Acta Paediatr. 2001 May;90(5):580-3
11430722
J Clin Oncol. 2001 May 15;19(10):2696-704
11352962
Folia Morphol (Warsz). 2004 Feb;63(1):91-3
15039909
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72
16168831